Shanghai Baolijia Chemical 保立佳
7 significant filings since 29 May 2026: 3 on guarantee or financial assistance, 3 on change of interest and 1 on major holder selling. The latest, on 5 Sep 2026: 关于公司及子公司担保事项的进展公告.
自 29 May 2026 起有 7 份重大公告：guarantee or financial assistance 3 份、change of interest 3 份、major holder selling 1 份。最新一份（5 Sep 2026）：关于公司及子公司担保事项的进展公告。
As of 25 Sep 2026 截至2026年9月25日
Shanghai Baolijia Chemical 保立佳 is a chemical products company listed on the Shenzhen Stock Exchange since 30 Jul 2021. The company reported a revenue decline of 21.4% in 2025 to RMB1.69bn, with a net loss of -RMB55.4m, though the loss narrowed from -RMB149.7m in 2024. Operating cash flow improved to RMB0.43 per share in 2025 from -RMB1.22 the prior year. However, the company faces financial risks: liabilities stood at 76.0% of assets as of 30 Jun 2026, and the current ratio was below 1 at 0.72, indicating short-term liquidity pressure. In the first half of 2026, the company turned to a loss of -RMB29.2m, reversing a prior-year profit. The stock has declined 9.8% over the past year, and the P/E ratio is not meaningful due to ongoing losses.
保立佳是一家化学制品公司，于2021年7月30日在深圳证券交易所上市。2025年公司营业收入同比下降21.4%至16.90亿元，归属于母公司股东的净利润为-5,542.2万元，较2024年-1.50亿元的亏损有所收窄。每股经营现金流由2024年的-1.22元改善至2025年的0.43元。但公司面临财务风险：截至2026年6月30日，资产负债率为76.0%，流动比率0.72，低于1，显示短期偿债压力。2026年上半年公司由盈转亏，归母净利润为-2,923.1万元。过去一年股价下跌9.8%，因持续亏损，市盈率（TTM）不适用。
| Flag 标记 | Risk 风险 | Mechanism 影响机制 |
|---|---|---|
| Attributable net loss in 2025 2025年归母净利润亏损 | The company reported a net loss in 2025. 公司2025年报告了净亏损。 | A net loss reduces retained earnings and weakens equity, limiting internal funding for operations or growth. Although the loss narrowed from 2024, the company remains unprofitable. 净亏损会减少留存收益，削弱股东权益，限制公司通过内部资金支持运营或扩张的能力。尽管亏损较2024年收窄，公司仍处于亏损状态。 |
| Revenue down 20% or more on the year before 营业收入同比下降20%或以上 | Revenue declined by more than 20% year-on-year in 2025. 2025年营业收入同比下滑超20%。 | A revenue drop of this scale may indicate weakening demand, loss of market share, or operational challenges, reducing the base for profit and cash generation. 如此幅度的收入下滑可能反映市场需求减弱、市场份额流失或经营困难，削弱盈利和现金流生成的基础。 |
| Liabilities at 70% of assets or more 资产负债率达70%或以上 | Liabilities are at 76.0% of assets, above the 70% threshold. 负债占资产比例达76.0%，超过70%的阈值。 | High leverage increases financial risk, especially if earnings or cash flow weaken further, potentially limiting access to new financing or increasing borrowing costs. 高杠杆加剧财务风险，若盈利或现金流进一步恶化，可能限制融资能力或提高借贷成本。 |
| Current ratio below 1: current liabilities exceed current assets 流动比率低于1：流动负债超过流动资产 | The current ratio is below 1, at 0.72. 流动比率低于1，为0.72。 | A current ratio below 1 means current liabilities exceed current assets, indicating potential difficulty in meeting short-term obligations without asset liquidation or external support. 流动比率低于1表示流动负债超过流动资产，显示公司在不依赖资产变现或外部支持的情况下，可能难以偿还短期债务。 |
- Whether the attributable net profit for the full year 2026 returns to profitability.
2026全年归母净利润是否回归盈利。 - Revenue trend in the 2026 full-year report compared to 2025's RMB1.69bn.
2026全年报告中营业收入相较于2025年16.90亿元的趋势。 - Operating cash flow per share in the 2026 full-year report, following RMB0.43 in 2025.
2026全年每股经营现金流，继2025年0.43元之后的表现。 - Liabilities to assets ratio in the 2026 year-end balance sheet, following 76.0% at mid-year.
2026年末资产负债率，继年中76.0%之后的变化。 - Current ratio in the 2026 full-year report, following 0.72 at mid-year.
2026全年报告中的流动比率，继年中0.72之后的变化。 - Whether the company discloses any distribution for 2026, as none has been recorded since 2026.
公司是否披露2026年度分红，因自2026年起尚无分配记录。
- Company: Shanghai Baolijia Chemical 保立佳, Shenzhen Stock Exchange 301037; industry Chemical Products; listed 30 Jul 2021.
公司：保立佳，深圳证券交易所 301037；行业：化学制品；上市日期：2021年7月30日。 - Close on 24 Sep 2026 RMB13.12; close on 24 Sep 2025 RMB14.55; one-year change -9.8%.
2026年9月24日收盘价13.12元；2025年9月24日收盘价14.55元；一年涨跌幅-9.8%。 - 52-week range RMB10.22 to RMB17.48.
52周区间10.22元至17.48元。 - Market capitalisation RMB1.82bn; P/E TTM not meaningful (loss-making); price to book 3.37x.
总市值18.24亿元；市盈率（TTM）不适用（亏损）；市净率3.37倍。 - Revenue 2025 RMB1.69bn; 2024 RMB2.15bn; change -21.4%.
营业收入2025年16.90亿元；2024年21.51亿元；同比-21.4%。 - Attributable net profit 2025 -RMB55.4m; 2024 -RMB149.7m; change +63.0% (the loss narrowed).
归属于母公司股东的净利润2025年-5,542.2万元；2024年-1.50亿元；同比+63.0%（亏损收窄）。 - Net profit excluding non-recurring items, 2025 change +50.4%.
2025年扣除非经常性损益后的净利润同比+50.4%。 - Basic EPS 2025 -RMB0.40; 2024 -RMB1.08.
基本每股收益2025年-0.40元；2024年-1.08元。 - Operating cash flow per share 2025 RMB0.43; 2024 -RMB1.22.
每股经营现金流2025年0.43元；2024年-1.22元。 - 2025 gross margin 12.7%; net margin -3.3%; ROE -9.2%.
2025年毛利率12.7%；净利率-3.3%；净资产收益率-9.2%。 - At 30 Jun 2026: liabilities to assets 76.0%; current ratio 0.72; quick ratio 0.64; receivable days 105; inventory days 29.
截至2026年6月30日：资产负债率76.0%；流动比率0.72；速动比率0.64；应收账款周转天数105；存货周转天数29。 - Period to 30 Jun 2026 (six months, not comparable with the full years above): revenue RMB847.9m, change -8.5%; attributable net profit -RMB29.2m, change -440.4% (from a profit to a loss); operating cash flow per share RMB0.67.
截至2026年6月30日的报告期（六个月，不可与上述全年数据直接比较）：营业收入8.48亿元，同比-8.5%；归母净利润-2,923.1万元，同比-440.4%（由盈转亏）；每股经营现金流0.67元。 - Ownership: actual controller 杨文瑜,杨惠静; controlling shareholder 杨文瑜; largest holder at 30 Jun 2026: 杨文瑜, 52.09%.
股权：实际控制人：杨文瑜,杨惠静；控股股东：杨文瑜；2026年6月30日第一大股东：杨文瑜，持股52.09%。 - No distribution is held in this database, which begins on 1 Jan 2026; earlier distributions are not shown.
本数据库自2026年1月1日起记录，其中无该公司的分配记录；此前的分配未予显示。 - Aurelian Grade E, score 22.4 of 100, graded within a peer group of 185 companies in its industry; no rank among peers is given.
金源评级E，得分22.4（满分100），于行业同业185家中评定；未提供其在同业中的排名。 - Not held for this report: receivable ageing, litigation case amounts, the order book, the auditor's opinion and key audit matters, segment revenue.
本报告未掌握：应收账款账龄、诉讼案件金额、在手订单、审计意见及关键审计事项、分部收入。